Straumann Holding AG
SIX:STMN

Watchlist Manager
Straumann Holding AG Logo
Straumann Holding AG
SIX:STMN
Watchlist
Price: 111.5 CHF 2.48% Market Closed
Market Cap: 17.8B CHF
Have any thoughts about
Straumann Holding AG?
Write Note

Intrinsic Value

The intrinsic value of one STMN stock under the Base Case scenario is 130.32 CHF. Compared to the current market price of 111.5 CHF, Straumann Holding AG is Undervalued by 14%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

STMN Intrinsic Value
130.32 CHF
Undervaluation 14%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Straumann Holding AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for STMN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about STMN?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Straumann Holding AG

Provide an overview of the primary business activities
of Straumann Holding AG.

What unique competitive advantages
does Straumann Holding AG hold over its rivals?

What risks and challenges
does Straumann Holding AG face in the near future?

Has there been any significant insider trading activity
in Straumann Holding AG recently?

Summarize the latest earnings call
of Straumann Holding AG.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Straumann Holding AG.

Provide P/S
for Straumann Holding AG.

Provide P/E
for Straumann Holding AG.

Provide P/OCF
for Straumann Holding AG.

Provide P/FCFE
for Straumann Holding AG.

Provide P/B
for Straumann Holding AG.

Provide EV/S
for Straumann Holding AG.

Provide EV/GP
for Straumann Holding AG.

Provide EV/EBITDA
for Straumann Holding AG.

Provide EV/EBIT
for Straumann Holding AG.

Provide EV/OCF
for Straumann Holding AG.

Provide EV/FCFF
for Straumann Holding AG.

Provide EV/IC
for Straumann Holding AG.

Show me price targets
for Straumann Holding AG made by professional analysts.

What are the Revenue projections
for Straumann Holding AG?

How accurate were the past Revenue estimates
for Straumann Holding AG?

What are the Net Income projections
for Straumann Holding AG?

How accurate were the past Net Income estimates
for Straumann Holding AG?

What are the EPS projections
for Straumann Holding AG?

How accurate were the past EPS estimates
for Straumann Holding AG?

What are the EBIT projections
for Straumann Holding AG?

How accurate were the past EBIT estimates
for Straumann Holding AG?

Compare the revenue forecasts
for Straumann Holding AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Straumann Holding AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Straumann Holding AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Straumann Holding AG compared to its peers.

Compare the P/E ratios
of Straumann Holding AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Straumann Holding AG with its peers.

Analyze the financial leverage
of Straumann Holding AG compared to its main competitors.

Show all profitability ratios
for Straumann Holding AG.

Provide ROE
for Straumann Holding AG.

Provide ROA
for Straumann Holding AG.

Provide ROIC
for Straumann Holding AG.

Provide ROCE
for Straumann Holding AG.

Provide Gross Margin
for Straumann Holding AG.

Provide Operating Margin
for Straumann Holding AG.

Provide Net Margin
for Straumann Holding AG.

Provide FCF Margin
for Straumann Holding AG.

Show all solvency ratios
for Straumann Holding AG.

Provide D/E Ratio
for Straumann Holding AG.

Provide D/A Ratio
for Straumann Holding AG.

Provide Interest Coverage Ratio
for Straumann Holding AG.

Provide Altman Z-Score Ratio
for Straumann Holding AG.

Provide Quick Ratio
for Straumann Holding AG.

Provide Current Ratio
for Straumann Holding AG.

Provide Cash Ratio
for Straumann Holding AG.

What is the historical Revenue growth
over the last 5 years for Straumann Holding AG?

What is the historical Net Income growth
over the last 5 years for Straumann Holding AG?

What is the current Free Cash Flow
of Straumann Holding AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Straumann Holding AG.

Business Breakdown

Straumann Holding AG, a leader in dental implant and restorative solutions, has carved out a significant niche in the global dental market. Founded in 1954 in Switzerland, the company has evolved from a small manufacturer into a powerhouse known for its emphasis on innovation and quality. With a portfolio that includes dental implants, prosthetics, digital dentistry, and orthodontic solutions, Straumann has positioned itself at the forefront of cutting-edge oral healthcare technologies. By leveraging advanced research and development, the company continually enhances its offerings, ensuring that dental professionals have access to the most effective tools for restoring patients' smiles and m...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Straumann Holding AG

Current Assets 1.5B
Cash & Short-Term Investments 343.9m
Receivables 601.7m
Other Current Assets 581m
Non-Current Assets 2B
Long-Term Investments 200.9m
PP&E 717.8m
Intangibles 894.9m
Other Non-Current Assets 138.3m
Current Liabilities 723m
Accounts Payable 473.5m
Other Current Liabilities 249.5m
Non-Current Liabilities 787.4m
Long-Term Debt 423m
Other Non-Current Liabilities 364.4m
Efficiency

Earnings Waterfall
Straumann Holding AG

Revenue
2.5B CHF
Cost of Revenue
-672.2m CHF
Gross Profit
1.8B CHF
Operating Expenses
-1.3B CHF
Operating Income
481.3m CHF
Other Expenses
-210.6m CHF
Net Income
270.7m CHF

Free Cash Flow Analysis
Straumann Holding AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q3 2024, Straumann Group reported an impressive organic revenue growth of 11.2%, totaling CHF 586 million, and confirming a full-year growth outlook of low double digits. The EMEA region was a standout performer with an 11.4% increase, driven by new products like the SIRIOS intraoral scanner. However, North America faced challenges due to high interest rates impacting patient consultations. Despite these hurdles, the company anticipates continued market share gains and is optimistic for Q4 as new product launches like iEXCEL are expected to boost results. Profitability is projected to remain between 27% and 28% at constant currency rates.

What is Earnings Call?
Fundamental Scores

STMN Profitability Score
Profitability Due Diligence

Straumann Holding AG's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROIC
Positive 3-Year Average ROE
64/100
Profitability
Score

Straumann Holding AG's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

STMN Solvency Score
Solvency Due Diligence

Straumann Holding AG's solvency score is 83/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
83/100
Solvency
Score

Straumann Holding AG's solvency score is 83/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

STMN Price Targets Summary
Straumann Holding AG

Wall Street analysts forecast STMN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STMN is 139.26 CHF with a low forecast of 101 CHF and a high forecast of 183.75 CHF.

Lowest
Price Target
101 CHF
9% Downside
Average
Price Target
139.26 CHF
25% Upside
Highest
Price Target
183.75 CHF
65% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for STMN?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for STMN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

STMN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Straumann Holding AG Logo
Straumann Holding AG

Country

Switzerland

Industry

Health Care

Market Cap

17.8B CHF

Dividend Yield

0.76%

Description

Straumann Holding AG is a CH-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Basel, Basel-Stadt and currently employs 9,054 full-time employees. Straumann Holding AG is a Switzerland-based company active in the field of implant and restorative dentistry and oral tissue regeneration. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann Holding AG also offers a range of services to the dental profession worldwide, including training and education, provided in collaboration with the International Team for Implantology (ITI). Its products and services are available in a number of countries through the Group’s headquarters and through a network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region and in Latin America, including Dental Wings Inc based in Canada and Createch Medical SL based in Spain.

Contact

BASEL-STADT
Basel
Peter Merian-Weg 12
+41619651111.0
www.straumann.com

IPO

1998-06-01

Employees

9 054

Officers

CEO, Interim Head of Dental Service Organizations & Member of Executive Management Board
Mr. Guillaume Daniellot
CFO & Member of Executive Management Board
Ms. Yang Xu
Regional Head of Latin America, CEO of Neodent & Member of Executive Management Board
Mr. Matthias Schupp
Regional Head Asia Pacific & Member of the Executive Management Board
Mr. Kok-Kien Loh
Regional Head of Europe, Middle East & Africa and Member of Executive Management Board
Mr. Holger Haderer
Regional Head of North America & Member of Executive Management Board
Mr. Aurelio Sahagun
Show More
Chief Operations & Supply Chain Officer and Member of Executive Management Board
Mr. SĂ©bastien Roche
Chief Consumer Officer & Member of Executive Management Board
Mr. Jason Forbes
Head of Integrated Dental Technologies & Member of Management Board
Mr. Florian Kirsch
Head of Implantology Business Unit (IBU) and Member of Executive Management Board
Mr. Andreas Utz
Show Less

See Also

Discover More
What is the Intrinsic Value of one STMN stock?

The intrinsic value of one STMN stock under the Base Case scenario is 130.32 CHF.

Is STMN stock undervalued or overvalued?

Compared to the current market price of 111.5 CHF, Straumann Holding AG is Undervalued by 14%.

Back to Top